DEVELOPMENT AND VALIDATION OF A STABILITY-INDICATING RP-LC METHOD FOR THE DETERMINATION OF ANTICANCER DRUG EPIRUBICIN IN PHARMACEUTICALS

In the present paper, sensitive, rapid, and different analytical methodology was developed for the determination of anticancer drug epirubicin (EPR). The mixture of epirubicin and moxifloxacin as internal standard was separated on a reversed phase Waters Spherisorb ODS1 column (250mm × 4.6mm × 5mm)...

Full description

Saved in:
Bibliographic Details
Published in:Journal of liquid chromatography & related technologies 2014-07, Vol.37 (11), p.1583-1596
Main Authors: Kurbanoglu, Sevinc, Palabiyik, Burcin Bozal, Gumustas, Mehmet, Şanlı, Senem, Uslu, Bengi, Ozkan, Sibel A.
Format: Article
Language:English
Subjects:
determination
epirubicin
liquid chromatography
stability-indicating high-performance
validation
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 1596
container_issue 11
container_start_page 1583
container_title Journal of liquid chromatography & related technologies
container_volume 37
creator Kurbanoglu, Sevinc
Palabiyik, Burcin Bozal
Gumustas, Mehmet
Şanlı, Senem
Uslu, Bengi
Ozkan, Sibel A.
description In the present paper, sensitive, rapid, and different analytical methodology was developed for the determination of anticancer drug epirubicin (EPR). The mixture of epirubicin and moxifloxacin as internal standard was separated on a reversed phase Waters Spherisorb ODS1 column (250mm × 4.6mm × 5mm) using acetonitrile/water (30:70 v/v) mixture containing 15 mM phosphoric acid as mobile phase at 0.6 mL min −1 flow rate and 30 C. Also degradation studies were conducted as stress conditions of UV light, acidic hydrolysis, alkaline hydrolysis, oxidation, and heat in oven (100°C), to evaluate the ability of the proposed method for the separation of EPR from its degradation products. The validated method suggests routine analysis of EPR in differently equipped laboratories.
doi_str_mv 10.1080/10826076.2013.803202
format article
fullrecord <record><control><sourceid>proquest_infor</sourceid><recordid>TN_cdi_proquest_journals_1507246031</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1544008943</sourcerecordid><originalsourceid>FETCH-LOGICAL-i272t-f83cd21dac8417400c17d30d81a9fecc3c4f8cd235ec5d7a5707d4844ac0bd103</originalsourceid><addsrcrecordid>eNpd0d1KwzAUB_AiCur0DbwIeONN58lHl3oltc22QJeOmolelZi2MKmrthviG_jYpkwRhHASyO8cDvw97wLDGEMI166QCfDJmACm4xAoAXLgneCAgB9w8njo3o74gzn2Tvv-BQDzgAQn3lciHkSaLRdCaRSpBD1EqUwiLTOFsimK0L2O7mQq9ZMvVSJj96NmKF_6aYwWQs-zBE2zHOm5QInQIl9I9destGtQschRkq9mSCxlvrqTsVTIneU8yhdRLFYDSu_PvKPaNH11_nOPvNVU6Hjup9lsAP6acLL165DakuDS2JBhzgAs5iWFMsTmpq6spZbVoRM0qGxQchNw4CULGTMWnksMdORd7ee-de37ruq3xeu6t1XTmE3V7voCB8xNDW8YdfTyH31pd93GbecUcMImQLFTt3u13tRt92o-2q4pi635bNqu7szGrvuCYiiGpIrfpIohqWKfFP0GGz961w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1507246031</pqid></control><display><type>article</type><title>DEVELOPMENT AND VALIDATION OF A STABILITY-INDICATING RP-LC METHOD FOR THE DETERMINATION OF ANTICANCER DRUG EPIRUBICIN IN PHARMACEUTICALS</title><source>Taylor and Francis Science and Technology Collection</source><creator>Kurbanoglu, Sevinc ; Palabiyik, Burcin Bozal ; Gumustas, Mehmet ; Şanlı, Senem ; Uslu, Bengi ; Ozkan, Sibel A.</creator><creatorcontrib>Kurbanoglu, Sevinc ; Palabiyik, Burcin Bozal ; Gumustas, Mehmet ; Şanlı, Senem ; Uslu, Bengi ; Ozkan, Sibel A.</creatorcontrib><description>In the present paper, sensitive, rapid, and different analytical methodology was developed for the determination of anticancer drug epirubicin (EPR). The mixture of epirubicin and moxifloxacin as internal standard was separated on a reversed phase Waters Spherisorb ODS1 column (250mm × 4.6mm × 5mm) using acetonitrile/water (30:70 v/v) mixture containing 15 mM phosphoric acid as mobile phase at 0.6 mL min −1 flow rate and 30 C. Also degradation studies were conducted as stress conditions of UV light, acidic hydrolysis, alkaline hydrolysis, oxidation, and heat in oven (100°C), to evaluate the ability of the proposed method for the separation of EPR from its degradation products. The validated method suggests routine analysis of EPR in differently equipped laboratories.</description><identifier>ISSN: 1082-6076</identifier><identifier>EISSN: 1520-572X</identifier><identifier>DOI: 10.1080/10826076.2013.803202</identifier><language>eng</language><publisher>Abingdon: Taylor &amp; Francis Group</publisher><subject>determination ; epirubicin ; liquid chromatography ; stability-indicating high-performance ; validation</subject><ispartof>Journal of liquid chromatography &amp; related technologies, 2014-07, Vol.37 (11), p.1583-1596</ispartof><rights>Copyright Taylor &amp; Francis Group, LLC 2014</rights><rights>Copyright Taylor &amp; Francis Group, LLC</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids></links><search><creatorcontrib>Kurbanoglu, Sevinc</creatorcontrib><creatorcontrib>Palabiyik, Burcin Bozal</creatorcontrib><creatorcontrib>Gumustas, Mehmet</creatorcontrib><creatorcontrib>Şanlı, Senem</creatorcontrib><creatorcontrib>Uslu, Bengi</creatorcontrib><creatorcontrib>Ozkan, Sibel A.</creatorcontrib><title>DEVELOPMENT AND VALIDATION OF A STABILITY-INDICATING RP-LC METHOD FOR THE DETERMINATION OF ANTICANCER DRUG EPIRUBICIN IN PHARMACEUTICALS</title><title>Journal of liquid chromatography &amp; related technologies</title><description>In the present paper, sensitive, rapid, and different analytical methodology was developed for the determination of anticancer drug epirubicin (EPR). The mixture of epirubicin and moxifloxacin as internal standard was separated on a reversed phase Waters Spherisorb ODS1 column (250mm × 4.6mm × 5mm) using acetonitrile/water (30:70 v/v) mixture containing 15 mM phosphoric acid as mobile phase at 0.6 mL min −1 flow rate and 30 C. Also degradation studies were conducted as stress conditions of UV light, acidic hydrolysis, alkaline hydrolysis, oxidation, and heat in oven (100°C), to evaluate the ability of the proposed method for the separation of EPR from its degradation products. The validated method suggests routine analysis of EPR in differently equipped laboratories.</description><subject>determination</subject><subject>epirubicin</subject><subject>liquid chromatography</subject><subject>stability-indicating high-performance</subject><subject>validation</subject><issn>1082-6076</issn><issn>1520-572X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNpd0d1KwzAUB_AiCur0DbwIeONN58lHl3oltc22QJeOmolelZi2MKmrthviG_jYpkwRhHASyO8cDvw97wLDGEMI166QCfDJmACm4xAoAXLgneCAgB9w8njo3o74gzn2Tvv-BQDzgAQn3lciHkSaLRdCaRSpBD1EqUwiLTOFsimK0L2O7mQq9ZMvVSJj96NmKF_6aYwWQs-zBE2zHOm5QInQIl9I9destGtQschRkq9mSCxlvrqTsVTIneU8yhdRLFYDSu_PvKPaNH11_nOPvNVU6Hjup9lsAP6acLL165DakuDS2JBhzgAs5iWFMsTmpq6spZbVoRM0qGxQchNw4CULGTMWnksMdORd7ee-de37ruq3xeu6t1XTmE3V7voCB8xNDW8YdfTyH31pd93GbecUcMImQLFTt3u13tRt92o-2q4pi635bNqu7szGrvuCYiiGpIrfpIohqWKfFP0GGz961w</recordid><startdate>20140703</startdate><enddate>20140703</enddate><creator>Kurbanoglu, Sevinc</creator><creator>Palabiyik, Burcin Bozal</creator><creator>Gumustas, Mehmet</creator><creator>Şanlı, Senem</creator><creator>Uslu, Bengi</creator><creator>Ozkan, Sibel A.</creator><general>Taylor &amp; Francis Group</general><general>Taylor &amp; Francis Ltd</general><scope>7QF</scope><scope>7QO</scope><scope>7QQ</scope><scope>7SE</scope><scope>7SR</scope><scope>7TB</scope><scope>7U5</scope><scope>7U7</scope><scope>8BQ</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H8G</scope><scope>JG9</scope><scope>KR7</scope><scope>L7M</scope><scope>P64</scope></search><sort><creationdate>20140703</creationdate><title>DEVELOPMENT AND VALIDATION OF A STABILITY-INDICATING RP-LC METHOD FOR THE DETERMINATION OF ANTICANCER DRUG EPIRUBICIN IN PHARMACEUTICALS</title><author>Kurbanoglu, Sevinc ; Palabiyik, Burcin Bozal ; Gumustas, Mehmet ; Şanlı, Senem ; Uslu, Bengi ; Ozkan, Sibel A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-i272t-f83cd21dac8417400c17d30d81a9fecc3c4f8cd235ec5d7a5707d4844ac0bd103</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>determination</topic><topic>epirubicin</topic><topic>liquid chromatography</topic><topic>stability-indicating high-performance</topic><topic>validation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kurbanoglu, Sevinc</creatorcontrib><creatorcontrib>Palabiyik, Burcin Bozal</creatorcontrib><creatorcontrib>Gumustas, Mehmet</creatorcontrib><creatorcontrib>Şanlı, Senem</creatorcontrib><creatorcontrib>Uslu, Bengi</creatorcontrib><creatorcontrib>Ozkan, Sibel A.</creatorcontrib><collection>Aluminium Industry Abstracts</collection><collection>Biotechnology Research Abstracts</collection><collection>Ceramic Abstracts</collection><collection>Corrosion Abstracts</collection><collection>Engineered Materials Abstracts</collection><collection>Mechanical &amp; Transportation Engineering Abstracts</collection><collection>Solid State and Superconductivity Abstracts</collection><collection>Toxicology Abstracts</collection><collection>METADEX</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Copper Technical Reference Library</collection><collection>Materials Research Database</collection><collection>Civil Engineering Abstracts</collection><collection>Advanced Technologies Database with Aerospace</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Journal of liquid chromatography &amp; related technologies</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kurbanoglu, Sevinc</au><au>Palabiyik, Burcin Bozal</au><au>Gumustas, Mehmet</au><au>Şanlı, Senem</au><au>Uslu, Bengi</au><au>Ozkan, Sibel A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>DEVELOPMENT AND VALIDATION OF A STABILITY-INDICATING RP-LC METHOD FOR THE DETERMINATION OF ANTICANCER DRUG EPIRUBICIN IN PHARMACEUTICALS</atitle><jtitle>Journal of liquid chromatography &amp; related technologies</jtitle><date>2014-07-03</date><risdate>2014</risdate><volume>37</volume><issue>11</issue><spage>1583</spage><epage>1596</epage><pages>1583-1596</pages><issn>1082-6076</issn><eissn>1520-572X</eissn><abstract>In the present paper, sensitive, rapid, and different analytical methodology was developed for the determination of anticancer drug epirubicin (EPR). The mixture of epirubicin and moxifloxacin as internal standard was separated on a reversed phase Waters Spherisorb ODS1 column (250mm × 4.6mm × 5mm) using acetonitrile/water (30:70 v/v) mixture containing 15 mM phosphoric acid as mobile phase at 0.6 mL min −1 flow rate and 30 C. Also degradation studies were conducted as stress conditions of UV light, acidic hydrolysis, alkaline hydrolysis, oxidation, and heat in oven (100°C), to evaluate the ability of the proposed method for the separation of EPR from its degradation products. The validated method suggests routine analysis of EPR in differently equipped laboratories.</abstract><cop>Abingdon</cop><pub>Taylor &amp; Francis Group</pub><doi>10.1080/10826076.2013.803202</doi><tpages>14</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1082-6076
ispartof Journal of liquid chromatography & related technologies, 2014-07, Vol.37 (11), p.1583-1596
issn 1082-6076
1520-572X
language eng
recordid cdi_proquest_journals_1507246031
source Taylor and Francis Science and Technology Collection
subjects determination
epirubicin
liquid chromatography
stability-indicating high-performance
validation
title DEVELOPMENT AND VALIDATION OF A STABILITY-INDICATING RP-LC METHOD FOR THE DETERMINATION OF ANTICANCER DRUG EPIRUBICIN IN PHARMACEUTICALS
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T20%3A36%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_infor&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=DEVELOPMENT%20AND%20VALIDATION%20OF%20A%20STABILITY-INDICATING%20RP-LC%20METHOD%20FOR%20THE%20DETERMINATION%20OF%20ANTICANCER%20DRUG%20EPIRUBICIN%20IN%20PHARMACEUTICALS&rft.jtitle=Journal%20of%20liquid%20chromatography%20&%20related%20technologies&rft.au=Kurbanoglu,%20Sevinc&rft.date=2014-07-03&rft.volume=37&rft.issue=11&rft.spage=1583&rft.epage=1596&rft.pages=1583-1596&rft.issn=1082-6076&rft.eissn=1520-572X&rft_id=info:doi/10.1080/10826076.2013.803202&rft_dat=%3Cproquest_infor%3E1544008943%3C/proquest_infor%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-i272t-f83cd21dac8417400c17d30d81a9fecc3c4f8cd235ec5d7a5707d4844ac0bd103%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1507246031&rft_id=info:pmid/&rfr_iscdi=true